QQQX Gains Ground Price Action and Key Levels to Watch Natco Pharma Shares Decline Sharply After Weak Q4 Results Net Profit Falls 34 YearonYear Core Laboratories Inc Q1 2026 Earnings EPS Miss on Weaker Demand and Seasonal Headwinds Trumps Remarks on Taiwan Independence Stir Geopolitical and Market Uncertainty TIC Solutions Inc TIC Q1 2026 Earnings Wide EPS Miss as Losses Deepen BGSF Q1 2026 Earnings EPS Misses Estimates Amid Revenue Challenges Enliven Therapeutics Inc Q1 2026 Earnings Narrower Loss Beats Street Estimates Amid Continued Pipeline Progress TCRT Q4 2023 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline TKC Q4 2025 Earnings Profitability Reported Amid Limited Revenue Disclosure API Q1 2026 Earnings EPS of 001 Reflects Narrowed Loss Amid Tepid Market Reception Haemonetics HAE Q1 2026 Earnings Slight EPS Beat Amidst Steady Operational Performance